Skip to content

Lyric Bio

Building next-generation 'Complex Therapeutics' manufacturing to improve access to life-saving medicines

See all companies

Lyric Bio, Inc. is expanding biomanufacturing to human donor-derived biologics by using proprietary tissue engineering technology. 

Website: https://www.lyricbio.com/
LinkedIn: https://www.linkedin.com/company/lyricbio/

RELATED NEWS

Lyric Bio, Inc. Closes $6.6 Million Seed Financing To Revolutionize Donor-Derived Therapeutics

December 2, 2025